SCHEMBL10145954

SCHEMBL10145954

Cn1c(=O)n(C2CCN(c3ncccn3)CC2)c2ccc(-c3ccccc3C(N)=O)cc21

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 6/20 0.47
MTOR P42345 6/20 0.47
SLC6A7 Q99884 2/20 0.41
FAAH O00519 2/20 0.38
MAP4K1 Q92918 1/20 0.38
DRD2 P14416 1/20 0.38
SLC6A4 P31645 1/20 0.38
CYP3A4 P08684 1/20 0.38
HSD11B1 P28845 1/20 0.38
PARP1 P09874 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CTSS P25774 2/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14992973 0.85 PIK3CA (0.51) PIK3CAMTORSLC6A7FAAHDRD2
SCHEMBL10145863 0.82 PARP2 (0.47) PIK3CAMTORDRD2SLC6A4HSD11B1
SCHEMBL30724611 0.72 EZH2 (0.48) PIK3CADRD2SLC6A4HSD11B1
SCHEMBL20496328 0.71 HSD11B1 (0.51) PIK3CAMTORDRD2SLC6A4CYP3A4
SCHEMBL30724631 0.70 KDM4E (0.46) PIK3CAMTORDRD2SLC6A4CYP3A4
SCHEMBL26698025 0.70 OPRD1 (0.43) PIK3CAMTORDRD2SLC6A4TSHR
SCHEMBL30770186 0.69 NPC1 (0.47) PIK3CAMTORSLC6A7MEN1KMT2A
SCHEMBL14992429 0.69 HSD11B1 (0.53) PIK3CAMTORDRD2SLC6A4CYP3A4
SCHEMBL30770212 0.68 PIK3CA (0.45) PIK3CAMTORFAAHCYP3A4TSHR
SCHEMBL26697914 0.68 PIK3CA (0.45) PIK3CAMTORFAAHCYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2603079-B1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME (US) 2018-09-19 EP disclosed
US-8993779-B2 Positive allosteric modulators of MGLUR2 MERCK SHARP & DOHME CORP. (US) 2015-03-31 US disclosed
US-8993779-B2 Positive allosteric modulators of MGLUR2 MERCK SHARP & DOHME CORP. (US) 2015-03-31 US disclosed
US-8993779-B2 Positive allosteric modulators of MGLUR2 MERCK SHARP & DOHME CORP. (US) 2015-03-31 US disclosed
US-20130143880-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME LLC 2013-06-06 US disclosed
US-20130143880-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME LLC 2013-06-06 US disclosed
US-20130143880-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME LLC 2013-06-06 US disclosed
WO-2012021382-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME CORP. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130143880-A1 POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 GRM2, GRIA2, GRM1 PIK3CA 1854/4885MTOR 1896/4885SLC6A7 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.